Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THAP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | BORCS8-MEF2B | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | C1orf106 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | EML6 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | CD33 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | ZNF248 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | HNRNPR | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | TNS4 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | ERICH6 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | LY6L | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |